HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jean-Christophe Marine Selected Research
Jean-Christophe Marine Research Topics
Disease
62
Neoplasms (Cancer)
12/2022 - 07/2004
38
Melanoma (Melanoma, Malignant)
01/2022 - 08/2012
7
Carcinogenesis
01/2018 - 04/2011
5
Neoplasm Metastasis (Metastasis)
01/2022 - 01/2009
3
Uveal melanoma
01/2022 - 01/2018
3
Disease Progression
01/2021 - 01/2018
3
Retinoblastoma (Glioblastoma, Retinal)
10/2014 - 11/2006
3
Breast Neoplasms (Breast Cancer)
07/2014 - 07/2004
3
Neuroblastoma
06/2011 - 10/2006
2
Residual Neoplasm
01/2021 - 01/2018
1
Glioma (Gliomas)
12/2022
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021
1
Trichothiodystrophy Syndromes
01/2020
1
Lung Neoplasms (Lung Cancer)
01/2020
1
Colonic Neoplasms (Colon Cancer)
01/2018
1
Colorectal Neoplasms (Colorectal Cancer)
01/2018
1
Endometrial Neoplasms (Endometrial Cancer)
12/2017
1
Fragile X Syndrome (Martin Bell Syndrome)
11/2017
1
Intellectual Disability (Idiocy)
11/2017
1
Nevus (Nevi)
01/2017
1
Basal Cell Carcinoma (Rodent Ulcer)
07/2015
Drug/Important Bio-Agent (IBA)
14
Proteins (Proteins, Gene)
FDA Link
01/2022 - 07/2004
10
RNA (Ribonucleic Acid)
IBA
12/2022 - 07/2004
9
Pharmaceutical Preparations
IBA
01/2022 - 07/2004
8
Long Noncoding RNA
IBA
01/2022 - 01/2016
7
Transcription Factors (Transcription Factor)
IBA
12/2020 - 12/2005
6
Oncogene Proteins (Oncogene Protein)
IBA
01/2018 - 02/2006
5
Messenger RNA (mRNA)
IBA
01/2020 - 12/2010
4
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2021 - 03/2016
4
Chromatin
IBA
12/2020 - 10/2014
4
MicroRNAs (MicroRNA)
IBA
11/2017 - 12/2010
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 11/2016
3
Antisense Oligonucleotides
IBA
01/2022 - 01/2016
3
Protein Isoforms (Isoforms)
IBA
01/2020 - 01/2016
3
DNA (Deoxyribonucleic Acid)
IBA
12/2019 - 10/2005
3
Retinaldehyde (Retinal)
IBA
10/2014 - 11/2006
3
nutlin 3
IBA
06/2011 - 10/2006
2
sphingosine 1-phosphate (sphingosine-1-phosphate)
IBA
01/2019 - 11/2016
2
Enzymes
IBA
01/2019 - 01/2018
2
Lipids
IBA
01/2018 - 11/2016
2
Catenins
IBA
01/2018 - 07/2015
2
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
06/2011 - 07/2004
2
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
04/2011 - 08/2010
1
nintedanib
IBA
01/2022
1
Programmed Cell Death 1 Receptor
IBA
01/2022
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
Collagen
IBA
01/2022
1
Cytarabine (Cytosar-U)
FDA Link
Generic
11/2021
1
venetoclax
IBA
11/2021
1
Doxycycline (Periostat)
FDA Link
Generic
01/2021
1
Nestin
IBA
01/2021
1
Mitogen-Activated Protein Kinases
IBA
01/2021
1
Tyrosine (L-Tyrosine)
FDA Link
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2021
1
6-methyladenine
IBA
01/2021
1
Melanins (Melanin)
IBA
01/2021
1
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
IBA
01/2021
1
Microphthalmia-Associated Transcription Factor
IBA
01/2021
1
N-methyladenosine
IBA
01/2021
1
Nucleosomes (Nucleosome)
IBA
12/2020
1
Protein Phosphatase 2 (Protein Phosphatase 2A)
IBA
01/2020
1
Phenanthrolines
IBA
01/2020
1
Cyclin-Dependent Kinase Inhibitor p27
IBA
01/2020
1
Cisplatin (Platino)
FDA Link
Generic
01/2020
1
Zinc Finger E-box Binding Homeobox 2
IBA
01/2020
1
Protective Agents
IBA
01/2020
1
Sphingolipids
IBA
01/2019
1
ABT-737
IBA
01/2019
1
Ceramides
IBA
01/2019
1
Phosphotransferases (Kinase)
IBA
11/2018
1
Hydrocarbons
IBA
11/2018
1
Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
IBA
11/2018
1
Resveratrol
IBA
11/2018
1
quisinostat
IBA
01/2018
1
Histone Deacetylase Inhibitors
IBA
01/2018
1
alvocidib (flavopiridol)
IBA
01/2018
1
Codon (Codons)
IBA
01/2018
1
Transfer RNA (tRNA)
IBA
01/2018
1
Uridine
IBA
01/2018
1
Fragile X Mental Retardation Protein
IBA
11/2017
1
Cyclin-Dependent Kinase Inhibitor p16
IBA
06/2017
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
06/2017
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
06/2017
1
Tensins
IBA
06/2017
1
Cytokines
IBA
11/2016
1
sphingosine kinase
IBA
11/2016
1
Chemokines
IBA
11/2016
1
SOXE Transcription Factors
IBA
03/2016
1
eprenetapopt
IBA
03/2016
1
Vemurafenib
IBA
03/2016
1
Drug Combinations
IBA
03/2016
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2016
1
Transcription Factor 4
IBA
01/2016
1
Histones (Histone)
IBA
04/2015
Therapy/Procedure
37
Therapeutics
12/2022 - 07/2004
5
Drug Therapy (Chemotherapy)
01/2020 - 08/2012
4
Immunotherapy
01/2022 - 01/2015
2
Precision Medicine
06/2017 - 01/2017
1
Ligation
12/2017